SLC12A5 and epilepsy: Nevertheless, since Cl− homeostasis is such an essential part of the balance between neuronal excitation and inhibition, SLC12A5 holds significant clinical potential, serving as both a therapeutic target and as a gene of risk due to susceptibility for pathogenic variants in epilepsies and epileptic encephalopathies.